HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
heparin sodium in 0.9% sodium chloride injection
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
heparin sodium in 0.9% sodium chloride injection Quick Finder
1 INDICATIONS AND USAGE
Heparin Sodium Injection in Sodium Chloride at a concentration of 2 units/mL is indicated as an anticoagulant to maintain catheter patency.
2 DOSAGE AND ADMINISTRATION
2.1 Preparation for Administration
Do not administer unless solution is clear and seal is intact.Parenteral drug products should be...
3 DOSAGE FORMS AND STRENGTHS
- •
- Injection: 1,000 USP units per 500 mL (2 units per mL) clear solution in a single-dose infusion bag
- •
- Injection: 2,000 USP units per 1,000 mL (2 units per mL) clear solution in a...
4 CONTRAINDICATIONS
The use of HEPARIN SODIUM IN SODIUM CHLORIDE is contraindicated in patients with the following conditions:
- •
- Uncontrollable active bleeding state, except when this is due to...
5 WARNINGS AND PRECAUTIONS
5.1 Hemorrhage
Avoid using heparin in the presence of major bleeding, except when the benefits of heparin therapy outweigh the potential...
6 ADVERSE REACTIONS
The following clinically significant adverse reactions are described elsewhere in the labeling:
- •
- Hemorrhage [see Warnings and Precautions (5....
7 DRUG INTERACTIONS
7.1 Oral Anticoagulants
Heparin sodium may prolong the one-stage prothrombin time. Therefore, when heparin sodium is given with dicumarol or...
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Risk Summary
There are no...
10 OVERDOSAGE
Bleeding is the chief sign of heparin overdosage.
Neutralization of heparin effect:
When clinical...
11 DESCRIPTION
Intravenous solutions with heparin sodium (derived from porcine intestinal mucosa) are sterile, nonpyrogenic fluids for intravenous administration. Each 100 mL contains heparin sodium 200 USP Units; sodium...
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
Heparin interacts with the naturally occurring plasma protein, Antithrombin III, to induce a conformational change,...
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
No long term studies in animals have been performed to evaluate carcinogenic...
16 HOW SUPPLIED/STORAGE AND HANDLING
Intravenous solutions with heparin sodium are available in single-dose containers as follows:
17 PATIENT COUNSELING INFORMATION
Hemorrhage
Inform patients that it may take them longer than usual to stop bleeding, that they may...
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.
(800)-332-1088.